Overview |
bs-14581R |
EMID1 Polyclonal Antibody |
ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC), ICC |
Rat |
Human, Mouse, Dog, Cow |
Specifications |
Unconjugated |
Rabbit |
KLH conjugated synthetic peptide derived from human EMID1 |
351-441/441 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
Target |
129080 |
Q96A84 |
Cytoplasm |
AW122071; CO 5; CTA-984G1.2; EMI domain containing 1; EMI domain containing protein 1; EMI domain-containing protein 1; EMI5; EMID 1; Emid1; EMID1_HUMAN; Emilin and multimerin domain containing protein 1; Emilin and multimerin domain-containing protein 1; EMU1; hEmu1; MGC50657; OTTMUSP00000005297; Protein Emu1; Putative emu1; RGD1565846; RP23-338J18.3. |
Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. |
Application Dilution |
ELISA |
1:500-1000 |
IHC-P |
1:200-400 |
IHC-F |
1:100-500 |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |
ICC |
1:100-500 |